Clinical trial Recruiting at 2 sites Interventional Ages 40 and up

Exercise to Improve Sleep in Parkinson's Disease

Official title: The Effects of Different Exercise Modalities on Sleep Quality and Architecture in People With Parkinson's Disease

Run by McGill University · NCT05644327 · Data updated 2026-11-12

This study tests whether different types of exercise can help people with Parkinson's disease sleep better and improve their overall quality of life.

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment150 (estimated)
SponsorMcGill University
Academic / other
Locations3 sites (Laval, Quebec and 2 other locations)
StatusRecruiting
StartedSeptember 1, 2021
Main results expectedDecember 30, 2027
Study endsDecember 30, 2027
Registry record updatedMarch 13, 2026
Trial IDNCT05644327 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with mild to moderate idiopathic Parkinson's disease experiencing poor sleep quality.

Probably not a fit

Patients with atypical parkinsonism, severe untreated obstructive sleep apnea, or other significant neurological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of three types of exercise—cardiovascular, resistance, and a combination of both—on sleep quality and architecture in individuals with Parkinson's disease. Participants will engage in their assigned exercise regimen or a control condition for 12 weeks, with assessments conducted at the start, after the intervention, and at an 8-week follow-up. The study aims to determine if improvements in sleep are linked to enhancements in quality of life aspects such as cognitive and motor function.

Why it matters

Potential benefit: If successful, this study could provide a non-pharmacological approach to improving sleep quality in patients with Parkinson's disease.

How similar studies have gone: Previous studies have suggested that exercise can improve sleep quality in various populations, indicating potential success for this approach in Parkinson's disease.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Persons with mild-moderate idiopathic Parkinson's Disease (Modified Hoehn \& Yahr Scale stages 0.5-3.5);
* On a stable dosage of medication during the previous month;
* Having poor sleep quality defined as a score \> 15 in the PDSS-2 and/or reporting subjective sleep complaints affecting their sleep quality;

Exclusion Criteria:

* Having atypical parkinsonism, dementia, stroke, or any other neurological condition;
* Presenting severe untreated obstructive sleep apnea (OSA);
* Having a Montreal Cognitive Assessment (MoCA) score \<18
* Having a Beck Depression Inventory score \>31;
* Having absolute contraindications to exercise;
* Having severe osteoporosis;
* Participating in an exercise or drug trial during the period of the study;
* Exceeding the physical activity levels recommended for the general population (≥150 minutes/week of moderate-intensity or ≥75 minutes/week of vigorous-intensity cardiovascular activity) and/or strengthening activities ≥2 days/week.

Where it's running

  • Jewish Rehabilitation Hospital
    Laval, Quebec, Canada
    Recruiting
  • Human Brain Control of Locomotion Laboratory
    Montreal, Quebec, Canada
    Recruiting
  • Cummings Centre
    Montreal, Quebec, Canada
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.